Pacific Biosciences Of California: Peers

The FY2025 (Dec) proxy of Pacific Biosciences Of California names 15 peer companies for pay. Among Pacific Biosciences Of California and these peers, CEO pay was the lowest of 11 and total shareholder return was the lowest of 11.

11th highest of 11in Pacific Biosciences Of California and its pay peers, FY2025 (Dec) by CEO pay:

$4.3M$13.8M

11th highest of 11in Pacific Biosciences Of California and its pay peers, FY2025 (Dec) by total shareholder return:

$7$86

Pay peer group, FY2025 (Dec) proxy

Twist Bioscience
Adaptive Biotechnologies
Veracyte
Castle Biosciences
10x Genomics
AbCellera Biologics
Fulgent Genetics
Repligen
Myriad Genetics
Cytek Biosciences
AzentaNot disclosedNot disclosed
Ginkgo Bioworks HoldingsNot disclosedNot disclosed
Guardant HealthNot disclosedNot disclosed
NeogenomicsNot disclosedNot disclosed
QuanterixNot disclosedNot disclosed
15 companies

Changes by year

FY2023 (Dec) proxy

  • AddedGinkgo Bioworks Holdingspay peer groupThe Compensation Committee added Ginkgo Bioworks Holdings, Inc., Inspire Medical Systems, Inc., and SomaLogic, Inc., each of which satisfied most or all of the targeted criteria described above
  • AddedInspire Medical Systemspay peer groupThe Compensation Committee added Ginkgo Bioworks Holdings, Inc., Inspire Medical Systems, Inc., and SomaLogic, Inc., each of which satisfied most or all of the targeted criteria described above
  • AddedSomaLogic, Inc.pay peer groupThe Compensation Committee added Ginkgo Bioworks Holdings, Inc., Inspire Medical Systems, Inc., and SomaLogic, Inc., each of which satisfied most or all of the targeted criteria described above
  • RemovedMaravai Lifesciences Holdingspay peer groupEach of Penumbra Inc., and Repligen Corporation was removed based on its market capitalization and revenue being above the parameters described above, and Maravai LifeSciences Holdings, Inc. was removed based on its revenue being above the parameters described above
  • RemovedRepligenpay peer groupEach of Penumbra Inc., and Repligen Corporation was removed based on its market capitalization and revenue being above the parameters described above, and Maravai LifeSciences Holdings, Inc. was removed based on its revenue being above the parameters described above

The comes from the company's proxy. CEO pay and of each company come from its own Pay versus Performance table for the same fiscal year. Each company counts TSR from its own start year, so two values compare only when the start years match.